GLAXOSMITHKLINE, LLC: $18.2M Department of Health and Human Services Contract
Summary
This $18.2M contract to private entity GlaxoSmithKline for Relenza stockpiling supports pandemic preparedness but does not directly impact any publicly traded company.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Private entity contract; no direct public equity exposure.
- 2.Contract supports ongoing pandemic preparedness efforts.
- 3.No material market implications from this award.
Market Implications
This contract has negligible direct market implications. No publicly traded tickers are linked. Investors should watch for similar but public awards in the influenza antiviral space.
⚡ Government Convergence
Active government convergence in this signal’s sector right now.
Over the last 90 days, 49 separate government actions have converged on Biodefense / Pandemic Preparedness. What that means: federal dollars are already moving — agencies are soliciting bids and awarding contracts, not just talking, and legislation and executive action are building the policy and funding tailwind behind it. When independent channels move together like this — 39 federal contracts, 6 procurement notices, 3 bills and 1 news — it's the clearest early tell that Washington is committing to biodefense / pandemic preparedness, the kind of build-up that reshapes the sector well before it's obvious in the headlines.
Converging government actions
- BillBeagle Brigade Act of 2023 · 2024-12-23
- BillNo Flight, No Fight Act of 2026 · 2026-02-05
- ContractGLOBAL HEALTH INVESTMENT CORPORATION: OTHER TRANSACTION AGREEMENT: BARDA VENTURES · 2026-04-30
- Procurement noticeSources Sought Notice - Pandemic Preparedness Plan Evaluation · 2026-05-13
- Procurement noticeRFI - Medical Countermeasures for the Treatment of Drug-Resistant Fungal Infections · 2026-05-21
- Procurement noticeRPP: BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-02
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-03
- Procurement noticeRequest for Project Proposal (RPP): BEACON Program - Medical Countermeasure (MCM) Candidate Integration and Subcontractor Management · 2026-06-11
- ContractEMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.: ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) · 2026-06-26
- Procurement noticePresolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response · 2026-07-30
- ContractSIGA TECHNOLOGIES, INC.: PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF · 2026-08-24
- ContractSTATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $809M Department of Homeland Security Grant · 2026-09-18
- ContractGLAXOSMITHKLINE, LLC: $45.5M Department of Health and Human Services Contract · 2026-09-25
- ContractKALEO, INC.: THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROVAL FOR 2-PAM AUTOI · 2026-09-28
Full Analysis
The Department of Health and Human Services awarded GlaxoSmithKline, LLC a $18.2M definitive contract for Relenza (zanamivir) Rotadisk, 5mg, for the period 2025-2027. Relenza is an influenza antiviral drug used for treatment and prophylaxis. The award is classified as a National Stockpile-related procurement under the Office of Assistant Secretary for Preparedness and Response. Despite the size, GlaxoSmithKline, LLC is not a publicly traded entity; it is a private limited liability company. No mapping to public tickers is possible without speculation. The contract supports broader biodefense and public health preparedness, a sector showing bipartisan support. Related bills like HR8840 (Fair Care Act) propose healthcare cost reforms but have low relevance to this specific antiviral procurement. Because the recipient is private, no supply chain or competitive beneficiaries can be reliably identified. The contract is routine and does not signal a shift in sector dynamics.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
GLAXOSMITHKLINE, LLC: $45.5M Department of Health and Human Services Contract
GLAXOSMITHKLINE, LLC: $27.3M Department of Health and Human Services Contract
GENENTECH USA, INC: $37.5M Department of Health and Human Services Contract
GLAXOSMITHKLINE, LLC: $81.3M Department of Health and Human Services Contract Vehicle
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Contract Details
Recipient
GLAXOSMITHKLINE, LLC
Award Amount
$18,199,980
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →